ALBANY, New York, December 10, 2015 /PRNewswire/ --
A recent report published by Transparency Market Research studies the U.S. vaccine market. The report provides an insightful assessment of the present dynamics as well as growth trajectory expected to be exhibited by the vaccines market across the U.S. The report is titled "U.S. Vaccine Market (Human Vaccines: Hepatitis, Influenza, Meningococcal, Pneumococcal, HPV, Combination Vaccines; Animal Vaccines: Canine, Feline, Porcine, Bovine, Ovine, Poultry and Equine) - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" and forecasts expansion of the market at a humble 4.3% CAGR between 2014 and 2020. In the last couple of years, the vaccine industry has successfully established itself as one of the fastest developing segments in the U.S. healthcare sector.
Browse Full U.S. Vaccine Market (Human Vaccines: Hepatitis, Influenza, Meningococcal, Pneumococcal, HPV, Combination Vaccines; Animal Vaccines: Canine, Feline, Porcine, Bovine, Ovine, Poultry and Equine) - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 Report @ http://www.transparencymarketresearch.com/us-vaccine-market.html
As reported by the Centers for Disease Control and Prevention (CDC), vaccination drives across the U.S. have successfully eradicated the prevalence of chronic ailments such as smallpox, polio, and diphtheria, while diseases such as rubella, tetanus, and measles have been effectively controlled. Therefore, as a preventive measure, vaccination has helped in saving the lives of millions of adults, children, and animals. The report classifies the U.S. vaccine market into animal and human vaccines to study the course of development demonstrated by the segments individually. The human vaccine market in the U.S. is likely to expand under the influence of growing awareness and low risk of side effects from vaccination.
Get Sample Report Copy of U.S Vaccine Market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=553
Strict regulations drafted by the federal government mandating immunization against certain ailments has also accelerated the demand for vaccines in the country. Meanwhile, the escalating incidence of zoonotic diseases among animals and the high risk of transferring the infection to humans have fuelled the market for animal vaccines in the U.S. Widespread pet ownership across the U.S. has significantly contributed to the thriving animal vaccines market in the country. Other factors such as increasing consumption of poultry meat and recent approvals of Once PMH IN and Prime Pac PRRS+ vaccines have also given an incredible momentum to the U.S. animal vaccine market.
Browse Press Release of U.S Vaccine Market: http://www.transparencymarketresearch.com/pressrelease/us-vaccine-market.htm
However, on the flip side, the approval process for vaccines in the U.S. is governed by stringent regulation, which hinders the U.S. vaccine market to an extent. In addition, high cost of new vaccine discovery and development is also likely to negatively impact the growth prospects of the market during the forecast period. "For above 90% of all vaccines produced in the U.S., the manufacturers have no option but to rely on cold chain logistics to ensure efficacy and prevent loss of potency by exposure to outside temperature. This is a primary reason inflating the prices of vaccines," stated a TMR analyst. The high cost of handling, storage, and transportation of vaccines are also capable of hampering the vaccine market in the U.S. to an extent. For the purpose of the study, the report segments the U.S. human vaccine market into adult and pediatric vaccines in terms of vaccine type. Human vaccines are administered to curb the incidence of diseases such human papillomavirus (HPV), hepatitis, meningococcal, influenza, pneumococcal, and others, which also forms the market categories for human vaccines based on antigens. The animal vaccine market is broadly classified into livestock and companion vaccines. Leading players in the highly competitive U.S. vaccines market such as Novartis International AG, GlaxoSmithKline plc, Merck & Co., Inc., Sanofi, and Pfizer, Ltd compete on the basis of drug discovery and innovation to obtain a major share in the market.
U.S. Human Vaccine Market, by Type
U.S. Human Vaccine Market, by Antigen
- Hepatitis (A & B)
- Human Papillomavirus (HPV)
- Combination Vaccines (DTaP, DTaP-Hep B-IPV, DTaP-IPV and DTaP-IPV)
U.S. Animal Vaccine Market, by Animal Type
- Companion Animal Vaccine Market
- Livestock Vaccine Market
Other Reports by Transparency Market Research:
- Meningococcal Vaccines Market Expected to Reach USD 4.4 Billion Globally in 2022: http://www.transparencymarketresearch.com/meningococcal-vaccines-market.html
- Adverse Impact of FMD on GDP to Drive Global Foot and Mouth Diseases Vaccines Market at 8.8%CAGR: http://www.transparencymarketresearch.com/foot-mouth-disease-vaccines.html
- Global Vaccine Market - Global Industry Analysis, Size, Share, Trends, Analysis, Growth And Forecast 2014 - 2020: http://www.transparencymarketresearch.com/global-vaccine-market.html
- DNA Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019: http://www.transparencymarketresearch.com/dna-vaccines-market.html
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
SOURCE Transparency Market Research